Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Kollman

Showing results (51-60 of 209) with videos related to

Pageof 21
Sort By:
Retina (Philadelphia, Pa.)|January 11, 2008
Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edemaIngrid U Scott, Neil M Bressler, Susan B Bressler, et al.
The Journal of Pediatrics|August 21, 2012
Diabetic ketoacidosis at diabetes onset: still an all too common threat in youthGeorgeanna J Klingensmith, William V Tamborlane, Jamie Wood, et al.
Diabetes Technology & Therapeutics|February 9, 2011
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoringDongyuan Xing, Craig Kollman, Roy W Beck, et al.
Diabetes Care|February 11, 2012
Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell functionJennifer Sherr, William V Tamborlane, Dongyuan Xing, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 17, 2009
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulationNeil M Bressler, Allison R Edwards, Roy W Beck, et al.
Diabetes Technology & Therapeutics|April 11, 2013
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis, , Bruce A Buckingham, et al.
Pediatric Diabetes|March 25, 2005
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) StudyWilliam V Tamborlane, Craig Kollman, Michael W Steffes, et al.
Pediatric Diabetes|June 21, 2018
Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registriesGeorgeanna J Klingensmith, Stefanie Lanzinger, William V Tamborlane, et al.
Diabetes Care|October 17, 2013
Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetesBruce Buckingham, Roy W Beck, Katrina J Ruedy, et al.
Diabetes Care|December 29, 2006
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetesDarrell M Wilson, Roy W Beck, William V Tamborlane, et al.
Pageof 21

Showing results (51-60 of 209) with videos related to

Sort By:
Pageof 21
Retina (Philadelphia, Pa.)|January 11, 2008
Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edemaIngrid U Scott, Neil M Bressler, Susan B Bressler, et al.
The Journal of Pediatrics|August 21, 2012
Diabetic ketoacidosis at diabetes onset: still an all too common threat in youthGeorgeanna J Klingensmith, William V Tamborlane, Jamie Wood, et al.
Diabetes Technology & Therapeutics|February 9, 2011
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoringDongyuan Xing, Craig Kollman, Roy W Beck, et al.
Diabetes Care|February 11, 2012
Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell functionJennifer Sherr, William V Tamborlane, Dongyuan Xing, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 17, 2009
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulationNeil M Bressler, Allison R Edwards, Roy W Beck, et al.
Diabetes Technology & Therapeutics|April 11, 2013
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis, , Bruce A Buckingham, et al.
Pediatric Diabetes|March 25, 2005
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) StudyWilliam V Tamborlane, Craig Kollman, Michael W Steffes, et al.
Pediatric Diabetes|June 21, 2018
Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registriesGeorgeanna J Klingensmith, Stefanie Lanzinger, William V Tamborlane, et al.
Diabetes Care|October 17, 2013
Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetesBruce Buckingham, Roy W Beck, Katrina J Ruedy, et al.
Diabetes Care|December 29, 2006
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetesDarrell M Wilson, Roy W Beck, William V Tamborlane, et al.
Pageof 21